Cognosci, Inc.
Records under this name other than patents Cognosci, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,730,979 | Methods for decreasing set in inhibiting protein phosphatase 2A (PP2A) and/or increasing the activity of cyclin-dependent kinase 5 (CDK5) by an APOE peptide Formerly held Lapsed on the fee record Ended Aug 15, 2025 · From the USPTO record | Lapsed on the fee record | Ended Aug 15, 2025 | From the USPTO record |
| US 8,034,762 | Treatment of subarachnoid hemorrhage with Apo E analogs Formerly held Lapsed on the fee record Ended Oct 11, 2023 · From the USPTO record | Lapsed on the fee record | Ended Oct 11, 2023 | From the USPTO record |
| US 7,947,645 | APO E analogs and methods for their use Formerly held Lapsed on the fee record Ended May 24, 2023 · From the USPTO record | Lapsed on the fee record | Ended May 24, 2023 | From the USPTO record |
| US 8,629,242 | Methods of inhibiting calcineurin with ApoE analogs Formerly held Lapsed on the fee record Ended Jan 14, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jan 14, 2022 | From the USPTO record |
| US 8,623,601 | Methods of Diagnosing Cancer Lapsed on the fee record Ended Jan 7, 2022 · High confidence | Lapsed on the fee record | Ended Jan 7, 2022 | High confidence |
| US 9,815,884 | ApoE peptide dimers and uses thereof Formerly held Lapsed on the fee record Ended Nov 14, 2021 · From the USPTO record | Lapsed on the fee record | Ended Nov 14, 2021 | From the USPTO record |
| US 9,809,640 | ApoE peptide dimers and uses thereof Formerly held Lapsed on the fee record Ended Nov 7, 2021 · From the USPTO record | Lapsed on the fee record | Ended Nov 7, 2021 | From the USPTO record |
| US 8,288,335 | ApoE analogs and methods for their use Formerly held Lapsed on the fee record Ended Oct 16, 2020 · From the USPTO record | Lapsed on the fee record | Ended Oct 16, 2020 | From the USPTO record |
| US 8,288,336 | Treatment of subarachnoid hemorrhage with ApoE analogs Formerly held Lapsed on the fee record Ended Oct 16, 2020 · From the USPTO record | Lapsed on the fee record | Ended Oct 16, 2020 | From the USPTO record |
| US 7,205,280 | Methods of Suppressing Microglial Activation Formerly held Term ended Term ended Jan 25, 2020 · Medium confidence | Term ended | Term ended Jan 25, 2020 | Medium confidence |